Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases

SH Tsai, PH Huang, YJ Hsu, YJ Peng, CH Lee… - Scientific reports, 2016 - nature.com
Hypoxia inducible factor-1α (HIF-1α) pathway is associated with many vascular diseases,
including atherosclerosis, arterial aneurysms, pulmonary hypertension and chronic venous …

Complex pathologies of angiotensin II-induced abdominal aortic aneurysms

A Daugherty, LA Cassis, H Lu - Journal of Zhejiang University Science B, 2011 - Springer
Angiotensin II (AngII) is the primary bioactive peptide of the renin angiotensin system that
plays a critical role in many cardiovascular diseases. Subcutaneous infusion of AngII into …

Peptide inhibitor of CXCL4–CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression

Y Iida, B Xu, H Xuan, KJ Glover, H Tanaka… - … , and vascular biology, 2013 - Am Heart Assoc
Objective—Macrophages are critical contributors to abdominal aortic aneurysm (AAA)
disease. We examined the ability of MKEY, a peptide inhibitor of CXCL4–CCL5 interaction …

[HTML][HTML] Editor's choice–pharmaceutical management of small abdominal aortic aneurysms: a systematic review of the clinical evidence

VBC Kokje, JF Hamming, JHN Lindeman - European Journal of Vascular …, 2015 - Elsevier
Background Management of abdominal aortic aneurysms (AAAs) relies on surgical repair of
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …

Current status of medical treatment for abdominal aortic aneurysm

K Kurosawa, JS Matsumura, D Yamanouchi - Circulation Journal, 2013 - jstage.jst.go.jp
2861 Medical Treatment for Abdominal Aortic Aneurysm ical treatments include anti-
hypertensives, statins, and antibiotics, some of which might work as MMP inhibitors. Tables …

Screening program of abdominal aortic aneurysm

M Sprynger, M Willems, H Van Damme… - …, 2019 - journals.sagepub.com
In Europe, the prevalence of abdominal aortic aneurysms (AAAs) in the elderly population
(≥ 65 year old) has declined in the past decades to< 4%. Aneurysmal degeneration of the …

The murine angiotensin II-induced abdominal aortic aneurysm model: rupture risk and inflammatory progression patterns

RY Cao, T Amand, MD Ford, U Piomelli… - Frontiers in …, 2010 - frontiersin.org
An abdominal aortic aneurysm (AAA) is an enlargement of the greatest artery in the body
defined as an increase in diameter of 1.5-fold. AAAs are common in the elderly population …

Opportunities in abdominal aortic aneurysm research: epidemiology, genetics, and pathophysiology

H Kuivaniemi, JR Elmore - Annals of vascular surgery, 2012 - Elsevier
Aortic aneurysms are a complex genetic disorder with known environmental risk factors such
as smoking. Along the length of the aorta, significant heterogeneity occurs in the distribution …

Administration of anti-inflammatory M2 macrophages suppresses progression of angiotensin II-induced aortic aneurysm in mice

S Ashida, A Yamawaki-Ogata, M Tokoro, M Mutsuga… - Scientific reports, 2023 - nature.com
Aortic aneurysm (AA) is a vascular disorder characterized pathologically by inflammatory
cell invasion and extracellular matrix (ECM) degradation. It is known that regulation of the …

Statin use and risk of cerebral aneurysm rupture: a hospital-based case–control study in Japan

Y Yoshimura, Y Murakami, M Saitoh, T Yokoi… - Journal of Stroke and …, 2014 - Elsevier
Background Recent reports have showed that some statins have protective effects in
experimental cerebral aneurysm models. We conducted a case–control study to investigate …